Schrodinger (NASDAQ:SDGR) & Aspyra (OTCMKTS:APYI) Head to Head Contrast

Schrodinger (NASDAQ:SDGR) and Aspyra (OTCMKTS:APYI) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, valuation and profitability.

Volatility and Risk

Schrodinger has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Comparatively, Aspyra has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for Schrodinger and Aspyra, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1	3	4	0	2.38
Aspyra	0	0	0	0	0.00

Schrodinger presently has a consensus target price of $25.71, suggesting a potential upside of 45.61%. Given Schrodinger’s stronger consensus rating and higher possible upside, equities analysts clearly believe Schrodinger is more favorable than Aspyra.

Insider and Institutional Ownership

79.1% of Schrodinger shares are held by institutional investors. 21.0% of Schrodinger shares are held by insiders. Comparatively, 23.9% of Aspyra shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Schrodinger and Aspyra”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$256.95 million	5.06	-$187.12 million	($2.41)	-7.33
Aspyra	N/A	N/A	N/A	N/A	N/A

Aspyra has lower revenue, but higher earnings than Schrodinger.

Profitability

This table compares Schrodinger and Aspyra’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Schrodinger	-68.49%	-48.24%	-24.21%
Aspyra	N/A	N/A	N/A

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.